Relief

Description

The Good Patch Relief is a topical patch designed to provide fast-acting relief from pain. Each package contains four patches that are water-resistant, allowing for extended wear. The formulation includes plant-derived ingredients such as menthol, lavender, arnica, and aloe vera, which are known for their soothing properties.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults over 18 years of age, the recommended dosage is one patch applied to the affected area. The patch should be carefully removed from its backing film prior to application. It is advised that the patch be applied no more than 3 to 4 times daily. Each patch may be worn for a maximum duration of 12 hours.

For children under 18 years of age, it is essential to consult a healthcare professional for appropriate dosing and administration guidance.

Contraindications

The use of this product is contraindicated in the following situations:

• Application of more than one patch at a time is prohibited due to the potential for increased systemic absorption and associated adverse effects.

• Concurrent use with other topical analgesics is contraindicated to avoid the risk of additive effects and potential toxicity.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. It is imperative to avoid contact with the eyes and other mucous membranes. Application to wounds or damaged skin is contraindicated, and care should be taken not to bandage the area tightly.

The use of this product is restricted to one patch at a time, and it should not be used concurrently with other topical analgesics. Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

In cases of pregnancy or breastfeeding, it is essential for individuals to seek guidance from a healthcare professional prior to use. Additionally, this product should be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated to use more than one patch at a time or to apply it concurrently with other topical analgesics.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

For pregnant or breastfeeding individuals, it is recommended to seek advice from a healthcare professional prior to use.

Additionally, it is crucial to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made without delay.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may lead to an increased risk of adverse effects without providing additional therapeutic benefit. Therefore, it is advised to avoid using this medication simultaneously with any other topical analgesic agents.

No specific drug or laboratory test interactions have been identified. As such, routine monitoring for interactions with other medications or laboratory tests is not necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 18 years of age should consult a healthcare professional prior to use. It is essential to evaluate the appropriateness of treatment and dosage for this population, as specific recommendations may vary based on individual clinical circumstances.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically studied in relation to dosage adjustments, special monitoring, or safety considerations for this medication. As such, there is no available information regarding the use of this drug in individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Serious side effects have been reported voluntarily through various channels, including surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the patch is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use more than one patch at a time and to avoid using the patch concurrently with other topical analgesics. It is important to counsel patients to stop using the product and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be advised to seek medical advice if their symptoms clear up and then recur within a few days.

When using the product, patients must be instructed to use it only as directed. They should avoid contact with the eyes and other mucous membranes, and not apply the patch to wounds or damaged skin. Patients should also be cautioned against bandaging the patch tightly and to adhere strictly to the usage instructions provided.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within its specified temperature range and is protected from moisture.

Additional Clinical Information

The product is administered topically. For adults over 18 years, the recommended usage is to apply one patch to the affected area, ensuring the backing film is carefully removed. This can be done no more than 3 to 4 times daily, with each patch being worn for a maximum of 12 hours. For children under 18 years of age, it is advised to consult a doctor prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)